Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) generation and scavenging refers to the complex biochemical network responsible for producing and neutralizing chemically reactive molecules containing oxygen, such as superoxide radicals and hydrogen peroxide (Sies et al., 2017, Nature Reviews Molecular Cell Biology). ROS are generated as natural byproducts of mitochondrial metabolism and by specialized enzymes like NADPH oxidases (NOX) for signaling and host defense (Forman & Zhang, 2021, Free Radical Biology and Medicine). Scavenging systems, including enzymes like superoxide dismutase (SOD), catalase, and glutathione peroxidase, maintain redox homeostasis by neutralizing excess ROS. An imbalance between generation and scavenging leads to oxidative stress, which causes damage to DNA, proteins, and lipids, contributing to the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). Therapeutic interventions aim to either inhibit ROS production or enhance scavenging capacity to mitigate tissue damage. However, because ROS also serve as vital signaling molecules, non-specific targeting can lead to significant safety concerns and therapeutic challenges.
Therapeutic agents modulate this process by directly scavenging free radicals, inhibiting ROS-producing enzymes such as NADPH oxidase (NOX) and xanthine oxidase, or inducing the expression of endogenous antioxidant enzymes through the activation of the Nrf2-Keap1 signaling pathway (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity; He et al., 2017, Journal of Clinical Medicine).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species (ROS) generation and scavenging (ROS generation and scavenging).